Phase1b to Evaluate Safety of AMG706 in Combination With Paclitaxel or Docetaxel for Breast Cancer

Clinical trial NCT00322400 · COMPLETED

Trial details

NCT number: NCT00322400
Sponsor: Amgen
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Locally Recurrent and Metastatic Breast Cancer

Start date: 2006-03-01
Primary completion: 2009-04-01
Enrollment: 46

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.